Scholarlink

<p>Adenoid hypertrophy (AH) is a common cause of upper airway obstruction and pediatric obstructive sleep apnea (OSA). While adenotonsillectomy remains the standard treatment, tonsillectomy carries higher risks. This study evaluates the effectiveness of adenoidectomy alone in improving quality of life (QOL) among children with AH and mild-to-moderate OSA. A prospective observational study was conducted over one year on 60 children (5–9 years) with adenoid hypertrophy and tonsillar enlargement &lt; grade 2. The Obstructive Sleep Disorders-6 (OSD-6) questionnaire was administered preoperatively and three months postoperatively. Domain and total scores were analyzed using paired t-tests, with p &lt; 0.05 considered significant. The study included 37 males (61.7%) and 23 females (38.3%) with a mean age of 8.98 ± 2.38 years. Grades 3 and 4 adenoid hypertrophy were observed in 41.7% and 58.3% of children, respectively. Postoperative analysis revealed significant improvement across all OSD-6 domains—physical distress, sleep disturbance, speech, emotional distress, and activity limitation (p &lt; 0.001). The total mean score decreased markedly from 15.55 ± 3.12 to 4.77 ± 1.74 (p &lt; 0.001), indicating substantial symptomatic relief and enhanced QOL. Adenoidectomy alone significantly improves sleep quality, physical symptoms, and overall QOL in children with AH and mild-to-moderate OSA. It offers a safe, effective, and less morbid alternative to adenotonsillectomy in appropriately selected cases. Further randomized controlled trials are warranted to confirm these findings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of Quality of Life in Children with Adenoid Hypertrophy and Snoring after Adenoidectomy Using OSD-6 Questionnaire: A Hospital-Based Study

  • 期刊论文

  • 发表日期：

    2026年3月30日

查看全文
  • Gopika Kalsotra,
  • Aditiya Saraf,
  • Himanshu Sharma,
  • Vikas Mahajan,
  • Danish Majeed Lone

摘要

Adenoid hypertrophy (AH) is a common cause of upper airway obstruction and pediatric obstructive sleep apnea (OSA). While adenotonsillectomy remains the standard treatment, tonsillectomy carries higher risks. This study evaluates the effectiveness of adenoidectomy alone in improving quality of life (QOL) among children with AH and mild-to-moderate OSA. A prospective observational study was conducted over one year on 60 children (5–9 years) with adenoid hypertrophy and tonsillar enlargement < grade 2. The Obstructive Sleep Disorders-6 (OSD-6) questionnaire was administered preoperatively and three months postoperatively. Domain and total scores were analyzed using paired t-tests, with p < 0.05 considered significant. The study included 37 males (61.7%) and 23 females (38.3%) with a mean age of 8.98 ± 2.38 years. Grades 3 and 4 adenoid hypertrophy were observed in 41.7% and 58.3% of children, respectively. Postoperative analysis revealed significant improvement across all OSD-6 domains—physical distress, sleep disturbance, speech, emotional distress, and activity limitation (p < 0.001). The total mean score decreased markedly from 15.55 ± 3.12 to 4.77 ± 1.74 (p < 0.001), indicating substantial symptomatic relief and enhanced QOL. Adenoidectomy alone significantly improves sleep quality, physical symptoms, and overall QOL in children with AH and mild-to-moderate OSA. It offers a safe, effective, and less morbid alternative to adenotonsillectomy in appropriately selected cases. Further randomized controlled trials are warranted to confirm these findings.